View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
January 20, 2022

LaBelforte launches business entities for Covid-19 nasal products development

The intranasal/inhalation products, which boost mucosal immunity, may advance the control of the disease.

Indian start-up LaBelforte has launched its special purpose business entities, Covidrops and Covinhaler, for facilitating immune optimising nasal and inhaled drug products development to treat Covid-19.

The two entities will aid in the development of these products to keep up with global advancements in the development of the second generation of therapies for Covid-19.

The company expects that the drug products that target engaging the local immune response at the nose and oral cavity, the common entry points for the virus, may add a new dimension to the worldwide response to the pandemic.

LaBelforte founder Dr Gaurav Raj Chhabra said: “Company’s target is to primarily facilitate co-development of Nasal sprays and Pocket Inhaler that are safe and effective ancillaries for both Covid-19 prophylaxis and therapy.           

“Our immediate attention is on Host-directed therapeutic options that safely and efficiently optimise Mucosal and barrier immunity by potentiating body’s own immune system through Immunogenic gene expression.”

The intranasal/inhalation drug products, which boost mucosal immunity as a first-line barrier to viral entry and shedding, may advance the control and prevention of the disease.

The company plans the launch of its products through Covidrops and Covinhaler in India by the second quarter of this year, after securing all required regulatory approvals and with consent from competent industry alliances.

LaBelforte Business Development head and co-founder Sanwale said: “In the first phase, our focus primarily has been on developing suitable collaborations globally to scout for the most promising new candidates under research, explore repurposed drug approach and get the IP groundwork ready.

“Next, as we move forward, we might as well opt for strategic alliances in the mainline pharma industry for smooth lab to market transitions.”

Related Companies

Free Report
img

Navigate your business through the ‘new normal’

COVID-19 continues to dominate headlines the world over. It has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities.  Faced with an explosion of conflicting information on how to plan and implement successful recovery strategies, decision-makers are in dire need of a single, reliable source of intelligence.   GlobalData’s COVID-19 Executive Briefing gives you access to unparalleled data and insights to successfully navigate the uncertain road to recovery across the world’s largest industries. Understand every aspect of this disruptive theme by delving into: 
  •  COVID-19 infection update, with statistics on the spread, testing by country, as well as the latest data on vaccines and therapeutic developments 
  • Economic impact overview, covering stock market indices, GDP, unemployment rates, policy responses & GlobalData’s economic recovery scorecards 
  • Sector developments, with access to sector insight summaries, cross-sector indices and the leaders and laggards in each industry vertical 
Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today. 
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU